"Both PML-s-IRIS and PML-d-IRIS are encountered in HIV/AIDS 1 and multiple sclerosis, particularly in JC virus-positive patients in the setting of prolonged treatment with natalizumab 2."
Line 8:133·'JC' has no definition. Spell it out if it's unfamiliar to the audience.